NasdaqGS:UTMD

Stock Analysis Report

Executive Summary

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally.

Snowflake

Fundamentals

Flawless balance sheet with proven track record.

Risks

  • Utah Medical Products is not covered by any analysts.

Similar Companies

Share Price & News

How has Utah Medical Products's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

2.3%

NasdaqGS:UTMD

-0.9%

US Medical Equipment

1.3%

US Market


1 Year Return

5.0%

NasdaqGS:UTMD

9.1%

US Medical Equipment

2.0%

US Market

UTMD underperformed the Medical Equipment industry which returned 8.7% over the past year.

UTMD outperformed the Market in United States of America which returned 1.7% over the past year.


Share holder returns

UTMDIndustryMarket
7 Day2.3%-0.9%1.3%
30 Day5.7%0.7%3.9%
90 Day23.3%4.4%3.4%
1 Year6.3%5.0%10.0%9.1%4.2%2.0%
3 Year73.2%66.4%70.7%65.5%47.2%37.6%
5 Year109.5%94.3%130.7%104.3%60.5%42.9%

Price Volatility Vs. Market

How volatile is Utah Medical Products's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Utah Medical Products undervalued based on future cash flows and its price relative to the stock market?

21.96x

Price to Earnings (PE) ratio


Intrinsic Value Based on Future Cash Flows

Utah Medical Products's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Utah Medical Products's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Utah Medical Products is good value based on earnings compared to the US Medical Equipment industry average.

Utah Medical Products is overvalued based on earnings compared to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Utah Medical Products, we can't assess if its growth is good value.


Price Based on Value of Assets

Utah Medical Products is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Utah Medical Products expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

-4.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Unable to determine if Utah Medical Products is high growth as no revenue estimate data is available.

Utah Medical Products's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.

Unable to compare Utah Medical Products's revenue growth to the United States of America market average as no estimate data is available.

Utah Medical Products's earnings are expected to decrease over the next 1-3 years, this is below the United States of America market average.

Utah Medical Products's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Utah Medical Products will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Utah Medical Products performed over the past 5 years?

5.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Utah Medical Products's year on year earnings growth rate has been positive over the past 5 years.

Utah Medical Products's 1-year earnings growth exceeds its 5-year average (77% vs 5.7%)

Utah Medical Products's earnings growth has exceeded the US Medical Equipment industry average in the past year (77% vs 28.9%).


Return on Equity

Utah Medical Products has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).


Return on Assets

Utah Medical Products used its assets more efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

Utah Medical Products's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).


Next Steps

Financial Health

How is Utah Medical Products's financial position?


Financial Position Analysis

Utah Medical Products is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Utah Medical Products's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Utah Medical Products has no debt.

Utah Medical Products has no debt compared to 5 years ago when it was 11.1%.

Utah Medical Products has no debt, it does not need to be covered by operating cash flow.

Utah Medical Products has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Low level of unsold assets.

Utah Medical Products has no debt, it does not need to be covered by short term assets.


Next Steps

Dividend

What is Utah Medical Products's current dividend yield, its reliability and sustainability?

1.11%

Current Dividend Yield


Dividend Yield and Payments Analysis

Utah Medical Products's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.45%).

Utah Medical Products's dividend is below the markets top 25% of dividend payers in United States of America (3.67%).

Dividends per share have been stable in the past 10 years.

Dividends per share have increased over the past 10 years.


Current Payout to Shareholders

Dividends paid are well covered by earnings (4.1x coverage).


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Utah Medical Products's salary, the management and board of directors tenure and is there insider trading?

22.2yrs

Average board tenure


CEO

Kevin Cornwell (72yo)

26.8yrs

Tenure

US$501,300

Compensation

Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah  ...


CEO Compensation Analysis

Kevin's remuneration is lower than average for companies of similar size in United States of America.

Kevin's compensation has been consistent with company performance over the past year, both up more than 20%.


Board Age and Tenure

22.2yrs

Average Tenure

72yo

Average Age

The average tenure for the Utah Medical Products board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellUS$35628 Feb 19
Barbara Payne
EntityIndividual
Role
Member of the Board of Directors
Director
Shares4
Max PriceUS$89.00
SellUS$130,42628 Feb 19
Barbara Payne
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1,521
Max PriceUS$85.75
SellUS$9222 Feb 19
Barbara Payne
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1
Max PriceUS$92.00
SellUS$2,12816 Feb 19
Barbara Payne
EntityIndividual
Role
Member of the Board of Directors
Director
Shares23
Max PriceUS$92.50
SellUS$225,62116 Feb 19
Barbara Payne
EntityIndividual
Role
Member of the Board of Directors
Director
Shares2,445
Max PriceUS$92.29
SellUS$28528 Nov 18
Barbara Payne
EntityIndividual
Role
Member of the Board of Directors
Director
Shares3
Max PriceUS$95.00
SellUS$102,88928 Nov 18
Barbara Payne
EntityIndividual
Role
Member of the Board of Directors
Director
Shares1,097
Max PriceUS$93.79

Ownership Breakdown


Management Team

  • Kevin Cornwell (72yo)

    Chairman

    • Tenure: 26.8yrs
    • Compensation: US$501.30k
  • Brian Koopman

    Principal Financial Officer & Controller

    • Tenure: 1.4yrs
    • Compensation: US$120.34k

Board Members

  • Kevin Cornwell (72yo)

    Chairman

    • Tenure: 26.8yrs
    • Compensation: US$501.30k
  • Paul Richins (59yo)

    Director

    • Tenure: 21.7yrs
    • Compensation: US$333.84k
  • Ernst Hoyer (81yo)

    Lead Director

    • Tenure: 0yrs
    • Compensation: US$32.00k
  • Barbara Payne (72yo)

    Director

    • Tenure: 22.7yrs
    • Compensation: US$25.00k
  • James Beeson (77yo)

    Independent Director

    • Tenure: 12.6yrs
    • Compensation: US$25.00k

Company Information

Utah Medical Products, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Utah Medical Products, Inc.
  • Ticker: UTMD
  • Exchange: NasdaqGS
  • Founded: 1978
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$368.612m
  • Shares outstanding: 3.72m
  • Website: https://www.utahmed.com

Number of Employees


Location

  • Utah Medical Products, Inc.
  • 7043 South 300 West
  • Midvale
  • Utah
  • 84047
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
UTMDNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDDec 1982

Biography

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring access ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/15 23:45
End of Day Share Price2019/09/13 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.